While the first coronavirus vaccine has received emergency use authorization from the FDA, the author of today’s article points out that “The coronavirus vaccine race isn’t over.” So which COVID […]
read more4 ‘Strong Buy’/‘Buy’ Biotech Stocks
The author of today’s article notes that, while the “upside in biotech sector has been led by positive developments at small companies, primarily the ones developing a vaccine or treatment […]
read moreThe Tailwinds Behind Biotech – And How Both Traders And Investors Can Profit With ETFs
“While volatility still permeates the broad market, one segment has seen a fairly consistent upward trend through the bulk of the year. That segment is, of course, biotech”, notes an […]
read moreWhich Frontrunner’s COVID-19 Vaccine Candidate May Hold The Most Promise – And Why?
Of four frontrunners in the race for a vaccine for COVID-19 – Moderna, Pfizer and BioNTech, Inovio Pharmaceuticals, and AstraZeneca – is there any indication at this point whose vaccine […]
read moreWhy This “Picks And Shovels” Stock Could Be A Better COVID-19 Play Than Moderna
Moderna could strike gold when it comes to its COVID-19 vaccine candidate – or it could flop. Either way, the under-the-radar “picks-and-shovels” stock highlighted in today’s article – one that […]
read moreTime To Jump In On Gold Buying With This “Prime Trading Opportunity”?
With COVID-19 cases surging across many parts of the US, extreme uncertainty pervades the market again. With gold considered the ultimate safe haven asset, when might be the right time […]
read moreCOVID & A Cannabis Comeback
Great euphoria surrounded the cannabis space – and then cannabis stocks collapsed. However, the author of today’s article notes that “for the first time in more than two years, there […]
read moreWhy Now May Be The Perfect Time To Buy This Biotech Stock – And Avoid This Other One
“A crucial aspect of success in investing in biotech stocks is that of timing,” notes the author of today’s article, who proceeds to examine one biotech stock where it appears […]
read moreThis Options Trade Could Net A Quick 300% Gain By Taking Advantage Of Financials’ Weakness
Today’s article outlines an options trade that could net a quick 300% gain by taking advantage of one of the weakest sectors in the market today (even before COVID-19 hit): […]
read more